State of the Art of Biochemical Markers in Metastatic Bone Disease and the Role of Bisphosphonates as Therapeutic Agents

2005 ◽  
Vol 1 (3) ◽  
pp. 225-241 ◽  
Author(s):  
Ioannis Kanakis ◽  
Achilleas Theocharis ◽  
Argiris Noulas ◽  
Nikos Karamanos
Keyword(s):  
Bone Disease ◽  
Biochemical Markers ◽  
State Of The Art ◽  
Therapeutic Agents ◽  
Metastatic Bone Disease

scholarly journals The role of postoperative radiation and coordination of care in patients with metastatic bone disease of the appendicular skeleton

2018 ◽  
Vol 9 (4) ◽  
Author(s):  
Andrew R. Summers ◽  
Travis Philipp ◽  
Jacob D. Mikula ◽  
Kenneth R. Gundle
Keyword(s):  
Radiation Therapy ◽  
Bone Disease ◽  
The United States ◽  
Metastatic Bone Disease ◽  
Appendicular Skeleton ◽  
Coordination Of Care ◽  
Coordinated Care ◽  
Orthopaedic Surgeons ◽  
Patients Experience

Metastatic bone disease affects approximately 300,000 people in the United States, and the burden is rising. These patients experience significant morbidity and decreased survival. The management of these patients requires coordinated care among a multidisciplinary team of physicians, including orthopaedic surgeons. This article reviews the role of radiation therapy after orthopaedic stabilization of impending or realized pathologic extremity fractures. Orthopaedic surgeons have an opportunity to benefit patients with metastatic bone disease by referring them for consideration of post-operative radiation therapy. Further research into rates of referral and the effect on clinical outcomes in this population is needed.

scholarly journals The role of 18F–NaF PET/CT in metastatic bone disease

2015 ◽  
Vol 4 (3) ◽  
pp. 92-97 ◽  
Author(s):  
Mine Araz ◽  
Gülseren Aras ◽  
Özlem N. Küçük
Keyword(s):  
Bone Disease ◽  
Metastatic Bone Disease ◽  
Pet Ct

The role of bisphosphonates in the treatment of painful metastatic bone disease: a review of phase III trials

Pain ◽  
1998 ◽  
Vol 78 (3) ◽  
pp. 157-169 ◽  
Author(s):  
F Fulfaro ◽  
A Casuccio ◽  
C Ticozzi ◽  
C Ripamonti
Keyword(s):  
Bone Disease ◽  
Metastatic Bone Disease ◽  
Phase Iii ◽  
Phase Iii Trials
Sign in / Sign up

Export Citation Format

Share Document